Canada - English - Health Canada

quest vitamins a div of purity life health products - beta-carotene; thiamine hydrochloride; vitamin b2; nicotinic acid; calcium d-pantothenate; pyridoxine hydrochloride; vitamin b12; folic acid; biotin; calcium ascorbate; ascorbyl palmitate; d-alpha tocopheryl acetate; calcium ascorbate; calcium d-pantothenate; zinc hvp chelate; selenium hvp chelate; choline chloride; inositol; retinol palmitate - capsule - 3330unit; 10mg; 5mg; 60mg; 40mg; 10mg; 10mcg; .04mg; 10mcg; 200mg; 19mg; 40unit; 25mg; 1mg; 1mg; 5mg; 60mg; 60mg; 200unit - beta-carotene 3330unit; thiamine hydrochloride 10mg; vitamin b2 5mg; nicotinic acid 60mg; calcium d-pantothenate 40mg; pyridoxine hydrochloride 10mg; vitamin b12 10mcg; folic acid .04mg; biotin 10mcg; calcium ascorbate 200mg; ascorbyl palmitate 19mg; d-alpha tocopheryl acetate 40unit; calcium ascorbate 25mg; calcium d-pantothenate 1mg; zinc hvp chelate 1mg; selenium hvp chelate 5mg; choline chloride 60mg; inositol 60mg; retinol palmitate 200unit - vitamins & minerals

Canada - English - Health Canada

quest vitamins a div of purity life health products - beta-carotene; retinol palmitate; ascorbic acid; d-alpha tocopheryl acid succinate; zinc (zinc sulfate); selenium (selenium hvp chelate) - tablet - 10000unit; 6500unit; 400mg; 100unit; 5mg; 40mcg - beta-carotene 10000unit; retinol palmitate 6500unit; ascorbic acid 400mg; d-alpha tocopheryl acid succinate 100unit; zinc (zinc sulfate) 5mg; selenium (selenium hvp chelate) 40mcg - vitamins & minerals

Canada - English - Health Canada

quest vitamins a div of purity life health products - iodine (potassium iodide); calcium (calcium phosphate); phosphorus (calcium phosphate); magnesium (magnesium oxide); potassium (potassium gluconate); zinc (zinc citrate); manganese (manganese gluconate); beta-carotene (provitamin a); vitamin d3; vitamin e (d-alpha tocopheryl acetate); ascorbic acid; vitamin b1 (thiamine hydrochloride); vitamin b2 (riboflavin); nicotinic acid; d-pantothenic acid (calcium d-pantothenate); vitamin b6 (pyridoxine hydrochloride); folic acid; biotin; vitamin b12; inositol; choline bitartrate; dl-methionine - tablet - 0.025mg; 80mg; 62.5mg; 25mg; 3.75mg; 2.5mg; 0.5mg; 2500unit; 100unit; 12.5unit; 37.5mg; 5mg; 6.25mg; 6.25mg; 6.25mg; 5.25mg; 0.2mg; 6.25mcg; 6.25mcg; 6.25mg; 6.25mg; 6.25mg - iodine (potassium iodide) 0.025mg; calcium (calcium phosphate) 80mg; phosphorus (calcium phosphate) 62.5mg; magnesium (magnesium oxide) 25mg; potassium (potassium gluconate) 3.75mg; zinc (zinc citrate) 2.5mg; manganese (manganese gluconate) 0.5mg; beta-carotene (provitamin a) 2500unit; vitamin d3 100unit; vitamin e (d-alpha tocopheryl acetate) 12.5unit; ascorbic acid 37.5mg; vitamin b1 (thiamine hydrochloride) 5mg; vitamin b2 (riboflavin) 6.25mg; nicotinic acid 6.25mg; d-pantothenic acid (calcium d-pantothenate) 6.25mg; vitamin b6 (pyridoxine hydrochloride) 5.25mg; folic acid 0.2mg; biotin 6.25mcg; vitamin b12 6.25mcg; inositol 6.25mg; choline bitartrate 6.25mg; dl-methionine 6.25mg - vitamins & minerals

Canada - English - Health Canada

nutricorp international - vitamin a (retinyl palmitate); vitamin e (dl-alpha tocopheryl acetate) - capsule - 100000unit; 20unit - vitamin a (retinyl palmitate) 100000unit; vitamin e (dl-alpha tocopheryl acetate) 20unit - vitamin a

Canada - English - Health Canada

nutricorp international - vitamin a (retinyl palmitate); vitamin e (dl-alpha tocopheryl acetate) - capsule - 200000unit; 40unit - vitamin a (retinyl palmitate) 200000unit; vitamin e (dl-alpha tocopheryl acetate) 40unit - vitamin a

United States - English - NLM (National Library of Medicine)

warrick pharmaceuticals corporation - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - ointment - 0.5 mg in 1 g - augmented betamethasone dipropionate ointment is indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. augmented betamethasone dipropionate ointment is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in this preparation.

United States - English - NLM (National Library of Medicine)

terrain pharmaceuticals - betamethasone acetate (unii: ti05ao53l7) (betamethasone - unii:9842x06q6m), betamethasone sodium phosphate (unii: 7bk02scl3w) (betamethasone - unii:9842x06q6m) - betamethasone acetate 3 mg in 1 ml - when oral therapy is not feasible, the intramuscular use of betamethasone sodium phosphate and betamethasone acetate injectable suspension is indicated as follows: allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. dermatologic diseases bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. hydrocortisone or cortisone is the drug of choice in primary or secondary adrenocortical insufficiency.  synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular

European Union - English - EMA (European Medicines Agency)

bayer ag  - interferon beta-1b - multiple sclerosis - immunostimulants, - betaferon is indicated for the treatment ofpatients with a single demyelinating event with an active inflammatory process, if it is severe enough to warrant treatment with intravenous corticosteroids, if alternative diagnoses have been excluded, and if they are determined to be at high risk of developing clinically definite multiple sclerosis;patients with relapsing-remitting multiple sclerosis and two or more relapses within the last two years;patients with secondary progressive multiple sclerosis with active disease, evidenced by relapses.

New Zealand - English - Ministry for Primary Industries

bayer new zealand limited - phenmedipham; metamitron; desmedipham; ethofumesate - phenmedipham 60 g/litre; metamitron 200 g/litre; desmedipham 60 g/litre; ethofumesate 60 g/litre - herbicide - herbicide - group c1+n

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - interferon beta-1b, quantity: 0.25 mg/ml - injection, powder for - excipient ingredients: albumin; mannitol - betaferon is indicated for the treatment of: - ambulatory patients with relapsing-remitting multiple sclerosis (ms) characterised by at least two attacks of neurologic dysfunction over a two year period followed by complete or incomplete recovery. - betaferon is also indicated for the reduction of frequency and severity of clinical relapses, and for the slowing of progression of disease in patients with secondary progressive multiple sclerosis. - the treatment of patients with a single clinical event suggestive of multiple sclerosis and at least two clinically silent magnetic resonance imaging (mri) lesions characteristic of multiple sclerosis, if alternative diagnoses have been excluded.